Chinese Academy of Medical Sciences

🇨🇳China
Ownership
Private, Subsidiary
Established
2004-07-08
Employees
-
Market Cap
-
Website
http://www.pinganzhengxing.com

Genetic Profile on Predicting Sensibility of Preoperative Chemoradiotherapy on Locally Advanced Rectal Carcinoma

First Posted Date
2013-08-29
Last Posted Date
2016-01-05
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
150
Registration Number
NCT01930942
Locations
🇨🇳

Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer

First Posted Date
2013-08-27
Last Posted Date
2015-02-23
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
33
Registration Number
NCT01928680
Locations
🇨🇳

Cancer Hospital, ChineseAMS, Beijing, Beijing, China

Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer

First Posted Date
2013-06-06
Last Posted Date
2013-06-06
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
35
Registration Number
NCT01871363
Locations
🇨🇳

Cancer Hospital, CAMS, Beijing, China

The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy to GI Cancer

First Posted Date
2013-05-29
Last Posted Date
2013-05-29
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
58
Registration Number
NCT01863420
Locations
🇨🇳

Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, Beijing, China

Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen

First Posted Date
2013-05-09
Last Posted Date
2013-05-09
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
50
Registration Number
NCT01850147
Locations
🇨🇳

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, China

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

First Posted Date
2013-03-22
Last Posted Date
2021-01-29
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
590
Registration Number
NCT01817023
Locations
🇨🇳

Jiangxi province cancer hospital, Nanchang, Jiangxi, China

🇨🇳

Department of Radiation oncology, Cancer hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China

🇨🇳

Cancer hospital, Chinese Academy of Medical Sciences, Beijing, China

and more 3 locations

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

First Posted Date
2013-02-25
Last Posted Date
2014-09-10
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
130
Registration Number
NCT01797900
Locations
🇨🇳

Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China

Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer

First Posted Date
2012-12-12
Last Posted Date
2012-12-12
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
40
Registration Number
NCT01747707
Locations
🇨🇳

Cancer Hospital & Institute, Chinese Academy of Medical Sciences, Beijing, China

Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer

First Posted Date
2012-09-06
Last Posted Date
2012-09-06
Lead Sponsor
Chinese Academy of Medical Sciences
Target Recruit Count
100
Registration Number
NCT01679327
Locations
🇨🇳

Cancer Institute&Hospital Chinese Academy of Medical Sciences, Beijing, China

© Copyright 2024. All Rights Reserved by MedPath